BG-00011

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameBG-00011

Drug Alias NameSTX-100hu3G9BG-00011

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized

Mechanisms of ActionIntegrin alpha-V/beta-6 antagonists

TargetsIntegrin alpha-V/beta-6

Therapy Area/IndicationsIdiopathic Pulmonary Fibrosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCzechiaBelgiumUnited States +[17]

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesBiogen Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesBiogen Inc

Active IndicationsN/A

Inactive IndicationsIdiopathic Pulmonary Fibrosis

ATC CodeN/A